Walter Christian Darbonne

Title: Walter Christian Darbonne: Innovator in Cancer Treatment

Introduction

Walter Christian Darbonne is a notable inventor based in Burlingame, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic methods. With a total of two patents to his name, Darbonne is recognized for his work in advancing medical science.

Latest Patents

Darbonne's latest patents include "Anti-Ly6G6D antibodies and methods of use." This invention provides anti-Ly6G6D antibodies and outlines methods for utilizing them effectively. Another significant patent is "Use of human epididymis protein 4 (HE4) for assessing responsiveness of MUC 16-positive cancer treatment." This invention relates to methods and kits that assess the responsiveness of cancers to MUC16 antagonists by monitoring HE4 expression. The methods involve measuring HE4 levels in a sample from a subject and comparing it with previous samples, potentially leading to the administration of a therapeutically effective amount of a MUC16 antagonist.

Career Highlights

Walter Christian Darbonne is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to cancer research.

Collaborations

Some of Darbonne's notable coworkers include Mark Lackner and Daniel Maslyar. Their collaborative efforts have played a crucial role in advancing the research and development of new cancer treatments.

Conclusion

Walter Christian Darbonne is a distinguished inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing medical science and improving therapeutic options for cancer patients.